Phase I study of LIQ-861 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 10 Jan 2018
At a glance
- Drugs LIQ-861 (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions
- Sponsors Liquidia Technologies
- 10 Jan 2018 New trial record
- 03 Jan 2018 According to the Liquidia Technologies, company expects to reports additional data from this study scientific conferences in 2018.